Events
Garmin Health and Metluma explore women’s health in upcoming webinar
Garmin Health, a division of global technology leader Garmin, is dedicated to working with collaborators to create empowering digital health solutions.
By integrating the Garmin product portfolio – including popular smartwatches and fitness trackers like the vívoactive 6, Venu 3s and Lily 2 – with Garmin Health API and SDK integration, companies like Metluma can leverage the high-quality sensor data for personalized health management for women.
The options and customisation are extensive, meeting the unique needs of women at various stages of life.
On April 24, Garmin Health Business Development Manager Mika Miyake will be joined by Metluma Co-Founders Georgie Drury and Dr. Nicole Avard for Garmin Health’s first webinar focused on women’s health.
During the session, they will explore how consumer devices like Garmin wearables can support women’s health by offering personalised, data-driven solutions.
Participants will also discover how Garmin’s biometric data integration enhances symptom tracking and health outcomes throughout menopause and beyond.
Powered by SiS: Women’s Health – a platform exclusively dedicated to driving advancements in women’s health through global events, corporate accelerator programs and a matchmaking platform – the webinar discusses Metluma’s Smart Health Community philosophy and the role of the UMA40 symptom tracker in personalized health management for women over 40.
It will demonstrate a compelling real-world use case for combining technology, data, and clinical insights to support symptom tracking, improve health outcomes, and enable women to take control of their health journey during menopause and beyond.
Event Details:
Women’s Health through Innovative Integration: Insights from Metluma powered by SiS: Women’s Health
April 24, 2025, 4:30PM CEST (UTC +2)
The webinar is free for attendees and registration is currently open.
Fashion, beauty and lifestyle retailers have joined the American Heart Association to raise awareness of heart disease in women.
The Go Red. Shop with Heart. campaign launched at the New York Stock Exchange on 30 January.
Retailers will ask for donations at checkout in February or donate a percentage of proceeds from selected items.
More than four in 10 women in the US have some form of cardiovascular disease, a term for heart and blood vessel conditions such as heart disease and stroke.
Heart disease and stroke kill more women in the US each year than all forms of cancer combined.
Brands taking part include Away, Commando, Lafayette 148, Michael Kors, Reebok, ShopSimon.com, Summersalt, Torrid and White & Warren.
More than 40 other nationwide retailers are also inviting customers to support the organisation this February through its Life Is Why campaign.
Nancy Brown is chief executive officer of the American Heart Association.
She said: “Nearly 1 in 3 women die from cardiovascular disease each year, yet women are still profoundly under-represented in the clinical research, science and medicine that could save their lives.
“Retailers and consumers are uniquely positioned to turn everyday moments into meaningful change through Go Red. Shop with Heart.”
According to the American Heart Association 2026 Heart Disease and Stroke Statistics Update, heart disease is the leading cause of death in the US and stroke is the number four cause of death.
The organisation projects that at least six in 10 US adults will have cardiovascular disease within the next 30 years and related costs are expected to triple.
However, approximately 80 per cent of cardiovascular disease is preventable through lifestyle changes.
Mindy Grossman is a volunteer board member at the American Heart Association and partner and vice chair of Consello.
Grossman said: “Retail has always been a powerful connector.
“Shop with Heart gives our industry a shared platform to lead with purpose and unite consumers in support of heart health.”
Women’s Health Week Europe is returning to London this year, from the 7–8 October, with the Emirates Stadium now confirmed as the official venue for the event.
Following a sold-out 2025 conference at the Barbican Centre, the move to Emirates Stadium marks a significant scale-up to match the momentum of the industry.
The 2026 event is expected to welcome 800+ attendees, with the entire ecosystem represented, from innovators and investors, to corporates, clinicians, and policymakers across two dedicated tracks focused on advancing women’s health through partnership and commercial growth.
Find out more about WHW Europe 2026 here.
Why the Emirates Stadium?
The WHW team have selected the Emirates Stadium not only for its scale, but for its symbolism.
As one of the most recognisable venues in European sport, the stadium represents what becomes possible when women are given the platform, infrastructure, and investment required to perform at the highest level.
The setting reflects Women’s Health Week’s ambition to position women’s health as a global priority at the intersection of healthcare, capital, sport, and economic growth.
Registration for Women’s Health Week Europe 2026 is now open, with an additional 50 per cent off super early bird pricing available until the end of Friday 30th January.
Further announcements, including speaker confirmations and agenda highlights, will be released in the coming months.
Make sure you don’t miss out, register your interest here.
Merck has launched a MENA femtech accelerator with Qatar Science & Technology Park to back startups improving women’s health.
The QSTP x Merck FemTech Accelerator aims to identify and support up to 30 startups developing solutions across women’s health, with a focus on innovations powered by artificial intelligence, robotics and materials science.
Selected companies will receive scaling support, market entry pathways and pilot opportunities to support commercial expansion into Qatar and the wider region.
Ahmed Aboelfadl, general manager for the Gulf at Merck, said: “Women’s health remains one of the most under-addressed areas in healthcare innovation globally.
“Through this partnership with QSTP, Merck is proud to support the growth of FemTech companies developing science- and technology-led solutions that can meaningfully improve health outcomes for women.
“By combining global scientific expertise with regional collaboration, this initiative will help accelerate innovation, enable real-world impact, and strengthen the ecosystem for women’s health across Qatar and the wider MENA region.”
The programme will feature a two-week immersion in Doha, where founders will engage with clinicians, regulators, investors and innovation leaders.
Rama Chakaki, president of QSTP, said: “At QSTP, we believe that meaningful innovation is inclusive.
“This accelerator is designed to support high-potential startups and generate measurable, scalable impact on women’s health across multiple markets.
“Leveraging Qatar’s growing innovation ecosystem alongside Merck’s global scientific leadership, we are creating pathways for FemTech solutions to be piloted, validated and adopted at regional and global scale.”
-
Insight4 weeks agoWomen’s health enters a new era – the trends shaping femtech in 2026
-
Insight3 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Features4 weeks agoBest menopause apps and products for 2026
-
Insight1 week agoParents sue IVF clinic after delivering someone else’s baby
-
Menopause2 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoHigher maternal blood pressure increases risk of pregnancy complications, study finds
-
Entrepreneur4 weeks agoXella Health closes US$3.7 million in pre-seed financing
-
Events4 weeks agoInside the first wave of speakers confirmed for Women’s Health Week USA 2026